[Featured Stocks] Celltrion and Healthcare Surge Over 5% Following Share Buyback Decision
[Asia Economy Reporter Ji Yeon-jin] Celltrion and Celltrion Healthcare, which decided to repurchase their own shares, are showing gains of over 5% on the 11th.
As of 10:16 AM on the day, Celltrion is trading at 196,500 KRW on the KOSPI market, up 5.08% from the previous day. Celltrion Healthcare, listed on KOSDAQ, is also recording 81,800 KRW, up 7.63% from the previous day.
The day before, Celltrion and Celltrion Healthcare held board meetings and announced that they decided to repurchase their own shares to stabilize stock prices and enhance shareholder value.
Hot Picks Today
"Buy Before June" - Securities Firms Recommend Stocks Expected to Rise Until 2028 [Weekend Money]
- From Next Year, "Name Your Price": Tokyo Real Estate Soars to 33-Year High [Mwonilissyu]
- "If It Has Hangul, It Sells Well": Booming Sales Despite Triple the Price... 'Hangul Marketing' Expands Overseas
- As Posts Celebrating "Eating Well Thanks to the KOSPI Bull Market" Surge, Why Is Consumer Spending Still Sluggish? [Weekend Money]
- "President Yoon, I Love You"... The Beautiful Woman in Her 20s Who Shouted 'Yoon Again' Was Actually
Celltrion plans to repurchase a total of 547,946 shares, with an estimated acquisition amount of about 100 billion KRW. Celltrion Healthcare plans to repurchase a total of 673,854 shares, with an estimated acquisition amount of about 50 billion KRW. Currently, the treasury shares held are 1,323,130 shares for Celltrion and 1,736,205 shares for Celltrion Healthcare.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.